Trial intelligence / Profile preview

Hydroxychloroquine/Azithromycin vs Hydroxychloroquine vs Placebo in Mild COVID-19

NCT04964583Phase 3Unknown

Sponsor
Coordinación de Investigación en Salud
Start
Jan 2021
Primary completion
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19), sponsored by Coordinación de Investigación en Salud. Status: unknown.

02

Drugs

hydroxychloroquineazithromycin
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04964583.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04964583.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call